Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nina D. Timberlake"'
Autor:
Krista A. Delviks-Frankenberry, Daniel Ackerman, Nina D. Timberlake, Maria Hamscher, Olga A. Nikolaitchik, Wei-Shau Hu, Bruce E. Torbett, Vinay K. Pathak
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 18, Iss , Pp 1023-1038 (2019)
Strategies to control HIV-1 replication without antiviral therapy are needed to achieve a functional cure. To exploit the innate antiviral function of restriction factor cytidine deaminase APOBEC3G (A3G), we developed self-activating lentiviral vecto
Externí odkaz:
https://doaj.org/article/8ce3c38bfdec4df3802934eb69e6970d
Autor:
Stosh Ozog, Craig X. Chen, Elizabeth Simpson, Olivia Garijo, Nina D. Timberlake, Petra Minder, Els Verhoeyen, Bruce E. Torbett
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 13, Iss , Pp 27-39 (2019)
Lentiviral vectors (LVs) pseudotyped with the measles virus hemagglutinin (H) and fusion (F) glycoproteins have been reported to more efficiently transduce hematopoietic stem and progenitor cells (HSPCs) compared with vesicular stomatitis virus glyco
Externí odkaz:
https://doaj.org/article/fddd9b144ec5464e8213e1eb8573ad39
Autor:
Daniel Ackerman, Vinay K. Pathak, Wei-Shau Hu, Olga A. Nikolaitchik, Krista A. Delviks-Frankenberry, Maria Hamscher, Bruce E. Torbett, Nina D. Timberlake
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 18, Iss, Pp 1023-1038 (2019)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
Strategies to control HIV-1 replication without antiviral therapy are needed to achieve a functional cure. To exploit the innate antiviral function of restriction factor cytidine deaminase APOBEC3G (A3G), we developed self-activating lentiviral vecto
Autor:
Olivia Garijo, Bruce E. Torbett, Elizabeth Simpson, Petra Minder, Craig X. Chen, Stosh Ozog, Els Verhoeyen, Nina D. Timberlake
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 13, Iss, Pp 27-39 (2019)
Molecular Therapy: Methods & Clinical Development, Vol 13, Iss, Pp 27-39 (2019)
Lentiviral vectors (LVs) pseudotyped with the measles virus hemagglutinin (H) and fusion (F) glycoproteins have been reported to more efficiently transduce hematopoietic stem and progenitor cells (HSPCs) compared with vesicular stomatitis virus glyco
Autor:
Dale L. Boger, Gabriella Sghia-Hughes, Christopher M. Glinkerman, Elizabeth Simpson, Guoli Shi, Raymond R. Carillo, Saritha S. D'Souza, Kip Hermann, Hans-Peter Kiem, Nina D. Timberlake, Scott A. Snyder, Lauren E Schefter, Jennifer E. Adair, Kevin G. Haworth, Byoung Y. Ryu, Brian P. Sorrentino, Olivia Garijo, Bruce E. Torbett, Igor I. Slukvin, Stosh Ozog, Alex A. Compton
Publikováno v:
Blood
Therapeutic gene delivery to hematopoietic stem cells (HSCs) holds great potential as a life-saving treatment of monogenic, oncologic, and infectious diseases. However, clinical gene therapy is severely limited by intrinsic HSC resistance to modifica
Autor:
Scott A. Snyder, Saritha S. D'Souza, Nina D. Timberlake, Sergio D. Catz, Igor I. Slukvin, Bruce E. Torbett, Stosh Ozog
Publikováno v:
Molecular Therapy. 24:S2-S3
A major obstacle to the success of gene therapy for hematologic disorders is the inefficiency of lentiviral vector (LV) gene transfer to hematopoietic stem cells (HSCs). Achieving clinically relevant gene delivery levels requires prolonged ex vivo cu